Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › tavapadon

tavapadon

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of tavapadon

3 trials tracked of tavapadon: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 17 citations.

3Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 3
  1. Phase 3 Fixed-Dose Trial in Early Parkinson's Disease (PD) Completed · 17 cited
  2. Phase 3 Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3) Completed · 16 cited
  3. Phase 3 Flexible-Dose Trial in Early Parkinson's Disease (PD) Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Tavapadon improves motor and functional outcomes in Parkinson's disease but raises adverse event risk
Neurology Meta-analysis
Tavapadon improves motor and functional outcomes in Parkinson's disease but raises adverse event risk Tavapadon Eases Parkinson's Motor Symptoms in Early Analysis
This meta-analysis pools data on tavapadon in Parkinson's disease and reports improvements in combined MDS-UPDRS Parts II + III (MD -8.80), …
A new Parkinson's drug, tavapadon, improved movement and daily function scores, but it also raised the risk of treatment-related side effect…
Nov 4, 2026
Tavapadon improves motor function and ON-time in patients with Parkinson's disease
Neurology Meta-analysis
Tavapadon improves motor function and ON-time in patients with Parkinson's disease Tavapadon Shows Improved Motor Function in Parkinson's Disease Patients
This meta-analysis of 1540 patients found that tavapadon improved MDS-UPDRS Parts II and III scores by 10.55 points and increased good ON-ti…
A review of clinical data suggests that the medication tavapadon may improve motor skills and daily movement for people with Parkinson's dis…
Aug 16, 2026